SG Americas Securities’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$473K Buy
+31,926
New +$473K ﹤0.01% 1556
2024
Q4
Sell
-29,125
Closed -$407K 3151
2024
Q3
$407K Buy
29,125
+12,241
+73% +$171K ﹤0.01% 1665
2024
Q2
$139K Buy
+16,884
New +$139K ﹤0.01% 2078
2023
Q4
Sell
-131,891
Closed -$1.18M 3073
2023
Q3
$1.18M Buy
+131,891
New +$1.18M 0.01% 1060
2023
Q2
Sell
-69,260
Closed -$1.56M 2808
2023
Q1
$1.56M Buy
+69,260
New +$1.56M 0.02% 741
2022
Q3
Sell
-33,635
Closed -$815K 3139
2022
Q2
$815K Buy
33,635
+9,790
+41% +$237K 0.01% 1334
2022
Q1
$614K Sell
23,845
-6,799
-22% -$175K ﹤0.01% 1564
2021
Q4
$951K Sell
30,644
-19,553
-39% -$607K 0.01% 1540
2021
Q3
$1.22M Buy
50,197
+35,705
+246% +$866K 0.01% 1585
2021
Q2
$211K Sell
14,492
-9,475
-40% -$138K ﹤0.01% 2094
2021
Q1
$598K Buy
23,967
+5,652
+31% +$141K ﹤0.01% 1716
2020
Q4
$499K Buy
18,315
+1,227
+7% +$33.4K ﹤0.01% 1747
2020
Q3
$315K Buy
17,088
+6,343
+59% +$117K ﹤0.01% 1600
2020
Q2
$219K Buy
10,745
+2,407
+29% +$49.1K ﹤0.01% 2403
2020
Q1
$122K Buy
+8,338
New +$122K ﹤0.01% 2418
2019
Q2
Sell
-6,328
Closed -$143K 2863
2019
Q1
$143K Buy
+6,328
New +$143K ﹤0.01% 2456
2017
Q4
Sell
-14,580
Closed -$363K 2972
2017
Q3
$363K Buy
14,580
+6,413
+79% +$160K ﹤0.01% 1810
2017
Q2
$158K Buy
8,167
+146
+2% +$2.83K ﹤0.01% 2267
2017
Q1
$148K Sell
8,021
-8,408
-51% -$155K ﹤0.01% 2370
2016
Q4
$311K Buy
+16,429
New +$311K ﹤0.01% 1785
2015
Q3
Sell
-4,773
Closed -$158K 2339
2015
Q2
$158K Sell
4,773
-3,359
-41% -$111K ﹤0.01% 1790
2015
Q1
$195K Buy
+8,132
New +$195K ﹤0.01% 1643